Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Pfizer's Paxlovid had very good results for Covid patients who took the drug within 3 days of infection in the clinical study. Here is an excellent article from Yale with the plus/minus of Paxlovid. $22 Billion in sales is impressive. Sorrento's Mpro appears to avoid the drug/drug interaction problem. It also should be significantly cheaper. We must await the efficacy results from the worldwide phase 2/3 trials which are being lined up right now. Great potential to say the least!
https://www.yalemedicine.org/news/13-things-to-know-paxlovid-covid-19#:~:text=But%20people%20should%20stop%20taking%20Paxlovid%20and%20call,4%20throat%20tightness%205%20hoarseness%206%20skin%20rash